Showing 12,841 - 12,860 results of 55,104 for search '(( a ((mean decrease) OR (linear decrease)) ) OR ( a ((greater decrease) OR (largest decrease)) ))', query time: 0.76s Refine Results
  1. 12841

    Differences between fellow eyes of acute and chronic primary angle closure (glaucoma): An ultrasound biomicroscopy quantitative study by Mengwei Li (1768756)

    Published 2018
    “…On multivariate logistic regression analyses, a 0.1 mm decrease in ACD (odds ratio [OR]: 0.705, 95%CI: 0.564–0.880, <i>P</i> = 0.002), ICPD (OR: 0.557, 95%CI: 0.335–0.925, <i>P</i> = 0.024), and a 0.1 mm increase in IRD (OR: 2.707, 95%CI: 1.025–7.149, <i>P</i> = 0.045), was significantly associated with occurrence of acute angle closures.…”
  2. 12842

    Features on GMSC dataset used in NATE. by Seongil Han (20490232)

    Published 2024
    “…Logistic regression is widely used in credit scoring due to its robustness, interpretability, and computational efficiency; however, its predictive power decreases when applied to complex or non-linear datasets, resulting in reduced accuracy. …”
  3. 12843

    Searching space for hyperparameters in Table 7. by Seongil Han (20490232)

    Published 2024
    “…Logistic regression is widely used in credit scoring due to its robustness, interpretability, and computational efficiency; however, its predictive power decreases when applied to complex or non-linear datasets, resulting in reduced accuracy. …”
  4. 12844

    GMSC dataset (IR: Imbalance Ratio). by Seongil Han (20490232)

    Published 2024
    “…Logistic regression is widely used in credit scoring due to its robustness, interpretability, and computational efficiency; however, its predictive power decreases when applied to complex or non-linear datasets, resulting in reduced accuracy. …”
  5. 12845

    Under-sampled dataset. by Seongil Han (20490232)

    Published 2024
    “…Logistic regression is widely used in credit scoring due to its robustness, interpretability, and computational efficiency; however, its predictive power decreases when applied to complex or non-linear datasets, resulting in reduced accuracy. …”
  6. 12846

    The system architecture of NATE. by Seongil Han (20490232)

    Published 2024
    “…Logistic regression is widely used in credit scoring due to its robustness, interpretability, and computational efficiency; however, its predictive power decreases when applied to complex or non-linear datasets, resulting in reduced accuracy. …”
  7. 12847

    Over-sampled dataset. by Seongil Han (20490232)

    Published 2024
    “…Logistic regression is widely used in credit scoring due to its robustness, interpretability, and computational efficiency; however, its predictive power decreases when applied to complex or non-linear datasets, resulting in reduced accuracy. …”
  8. 12848

    Subgroup analysis. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  9. 12849

    Study outcomes. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  10. 12850

    The percentage of cells with protein aggregates cotransfected with αA- and αB-crystallin or R120G αB-crystallin (αBM) genes by Bing-Fen Liu (81305)

    Published 2011
    “…</p><p></p> The x-axis labels are either RED-αB- or the pairs of GFP-αA- and RED-αB-crystallin. A four-fold decrease of cells with protein aggregates was observed for cotransfection of αA- and αB-crystallin (the asterisk indicates a p=0.006), but only about a 1.5 fold decrease for cotransfection of αA- and αBM-crystallin (the double asterisk indicates a p=0.02). …”
  11. 12851

    Spatial distribution of 12 class B notifiable infectious diseases in China: A retrospective study by Bin Zhu (182882)

    Published 2018
    “…<div><p>Background</p><p>China is the largest developing country with a relatively developed public health system. …”
  12. 12852
  13. 12853
  14. 12854

    Rhinorrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  15. 12855

    Vomit-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  16. 12856

    Symptoms free-days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  17. 12857

    Respiratory symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  18. 12858

    Other symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  19. 12859

    Diarrhea-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”
  20. 12860

    Gastrointestinal symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…<div><p>Background</p><p>Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent <i>in vitro</i> activity against SARS-CoV-2 virus. …”